Morphological analysis and immunohistochemical staining of LN sections harvested between days 0 and 28 p.i. from AGMs described in the legend to Fig. 1. (A) A 5-μm section of PFA-fixed paraffin-embedded LN, stained with hematoxylin-eosin; (B to H) 5-μm sections of PFA-fixed paraffin-embedded or cryopreserved OCT-embedded LN, stained by the AP–anti-AP method (11) and counterstained with Harris hematoxylin. No significant differences were observed between acutely infected and noninfected animals or within the same animal before and after infection. Representative sections are shown. (A) Classical histopathologic pattern of LN sections from AGM acutely infected with SIVagm (animal 96001, 10 days p.i., inguinal LN). (B) Typical image of the FDC network in LN from acutely SIVagm-infected AGM (animal 96001, 17 days p.i.). This frozen section of inguinal LN was stained with an anti-FDC MAb (DRC-1; Dako). (C) (D) Paraffin-embedded LN sections (animal 96001, inguinal LN) taken at days 0 and day 28 p.i., respectively, stained with a pan-B MAb (Dako). (E) Typical image of CD68+ cells distribution in LNs of infected and noninfected AGMs. Animal 96023 (day 0) is shown in this frozen section of inguinal LN stained with an anti-CD68 MAb (KiM7; Valbiotech). (F) Representative frozen LN section from acutely SIVagm-infected AGM (animal 96001, 10 days p.i., inguinal LN), stained with an anti-CD4 MAb (F101.69; Sanofi Recherche). (G and H) Frozen LN sections of animals 96014 (day 0, axillary LN) and 96011 (day 14 p.i., axillary LN), respectively, stained with an anti-CD8 MAb (Leu-2a; Becton Dickinson).